Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically

Y F Zhai1, H Beittenmiller, B Wang

  • 1Department of Pharmacology, Michigan State University, East Lansing 48824.

Cancer Research
|May 15, 1993
PubMed

Insights

This study reveals that specific protein tyrosine phosphatases (PTPases), LAR and PTP1B, are significantly upregulated in human breast cancer cells and rat mammary tumors. This PTPase upregulation correlates with neu oncogene expression and tumorigenicity, suggesting a key role in breast cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Protein tyrosine phosphorylation/dephosphorylation regulates cell proliferation and is modulated by protein tyrosine kinases and phosphatases (PTPases).
  • The role of PTPases in human breast tumorigenesis is largely unexplored, unlike the extensive research on protein tyrosine kinases.

Purpose of the Study:

  • To investigate the role of specific PTPases in human breast tumorigenesis.
  • To determine if PTPase expression is altered in response to neu oncogene activation and subsequent tumor formation.

Main Methods:

  • Activated neu oncogene introduced into a human breast epithelial cell line (184B5).
  • Tumorigenicity assessed by inoculation into athymic nude mice.
  • Expression levels of specific PTPases (LAR, PTP1B, TC-PTP, CD45) analyzed at mRNA and protein levels in cell lines and tumors.
  • Comparison with rat mammary carcinomas induced by neu or 7,12-dimethylbenzanthracene.

Main Results:

  • Neu-transformed cells and derived tumors showed a striking increase in LAR and PTP1B PTPase expression at both mRNA and protein levels.
  • TC-PTP expression showed only a slight increase, and CD45 expression was undetectable.
  • Elevated neu expression and differential expression of P185neu with LAR/PTP1B correlated directly with tumorigenicity.
  • Rat mammary carcinomas with elevated neu expression exhibited sharply increased LAR-PTPase expression compared to those with low neu expression.

Conclusions:

  • This study provides the first evidence of consistent and substantial increases in specific PTPase expression (LAR, PTP1B) in human breast carcinoma cells and neu-induced rat mammary carcinomas.
  • The observed relationship between P185neu-protein tyrosine kinase expression and specific PTPase expression may be critical in human breast tumorigenesis.

Related Concept Videos

Enzyme-linked Receptors01:13

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: